Conference abstract
Conference abstractPublished 18 Aug 2016
Proteomic variability and inflammation: Novel biomarkers and pathways
Banaras Hindu University, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Numerous studies indicate that persistent inflammation importantly contributes to the pathophysiology of many chronic human diseases, including cardiovascular diseases, diabetes, cancer, arthritis, neurodegerative and autoimmune disorders. Interacting cells (among them mononuclear phagocytes, T cells, B cells, natural killer cells and mast cells), all thought to originate from circulating hematopoietic and immune precursors and key resident cells of the tissues orchestrate aspects of the acute and chronic inflammation that underlie diseases of many organs. Inflammatory diseases are accompanied by a coordinated series of common mechanisms that is initiated by expression of cytokines, growth factors, mitogens and morphogens leading to a disturbance in homeostatic balance causing oxidative stress, tissue injury, extracellular matrix remodeling, angiogenesis and fibrosis in diverse target tissues. Arterial disease atherosclerosis features prominently among diseases that involve inflammatory mechanisms. Serum lipoproteins diffusing through extracellular space become entangled in the arterial space and begin to undergo oxidative and covalent modifications that render them proinflammatory in this disease. Local recruitment of blood leukocytes follows with progression that involves many inflammatory mediators that are modulated by interacting cells of the arterial wall and immune (both innate and adaptive) systems and the homeostatic balance between normal proteolytic remodeling and inhibition of extracellular proteolytic activity tips toward excessive tissue destruction. Structural deterioration can result in erosion or rupture of the plaque cap, which directly precipitates arterial thrombosis with frequently disastrous consequences, all these complications of the disease may intimately involve proteomic variability contributing to inflammatory mechanisms. A better understanding of the inflammatory, molecules and mechanisms should result in novel strategies to the detrimental effects of chronic inflammation, control of the inflammatory mechanisms in various diseases and may aid the development of potential molecular targets to favorably modify inflammatory diseases.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 29 Apr 2024
Characterization of Novel Biomarkers for Prostate Cancer Diagnosis Using Mass Spectrometry-based Proteomics
Conference abstract · 16 May 2018
Applications of KREX, a novel functional proteomics technology for autoantibody biomarker discovery
Conference abstract · 10 Aug 2017
Discovery and quantitation of novel fatty liver and fibrosis biomarkers using proteomics
Conference abstract · 7 May 2018
Antibody-proteases as a novel biomarker and a unique target to suit translational tools to be applied for biodesign and bioengineering
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectBiochemistry & Biotechnology
- SubjectImmunology & Microbiology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Tripathi Rajavashisth”
